Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jun 21, 2012 |
committed to rules |
Jun 11, 2012 |
advanced to third reading |
Jun 06, 2012 |
2nd report cal. |
Jun 05, 2012 |
1st report cal.1084 |
Apr 27, 2012 |
referred to health |
Senate Bill S7102
2011-2012 Legislative Session
Sponsored By
(D) Senate District
Archive: Last Bill Status - In Senate Committee Rules Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
Votes
2011-S7102 (ACTIVE) - Details
2011-S7102 (ACTIVE) - Sponsor Memo
BILL NUMBER:S7102 TITLE OF BILL: An act to amend the public health law, in relation to including substances designated pursuant to the federal Analog Act within the definition of controlled substances PURPOSE OR GENERAL IDEA OF BILL: This bill will give state drug and law enforcement agencies and individ- uals the another tool to combat the quickly moving world of designer drugs. The Federal Analog Act (21 use § 813) allows scheduling and enforcement against drugs which are substantially structurally similar to those in schedule I or II. This bill will incorporate substances scheduled under this act into New York State Public Health Law. SUMMARY OF SPECIFIC PROVISIONS: Section 1 amends Public Health Law Section 3306 to incorporate the Federal Analog Act into New York State's Drug Scheduling provisions. JUSTIFICATION: Currently under New York State Law, only a narrow selection of scheduled substances have analog protection. That is, manufacturers often only need to chemically "tweak" a drug to avoid scheduling. This creates a game of cat and mouse, with legislation and enforcement far slower to act than the manufacturers of designer drugs.
2011-S7102 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 7102 I N S E N A T E April 27, 2012 ___________ Introduced by Sen. KLEIN -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to including substances designated pursuant to the federal Analog Act within the definition of controlled substances THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The opening paragraph of section 3306 of the public health law, as added by chapter 664 of the laws of 1985, is amended to read as follows: There are hereby established five schedules of controlled substances, to be known as schedules I, II, III, IV and V respectively. Such sched- ules shall consist of the following substances by whatever name or chem- ical designation known, AND SHALL INCLUDE ANY SUCH SUBSTANCES AS SHALL BE DESIGNATED PURSUANT TO THE FEDERAL ANALOG ACT (21 U.S.C. S 813): S 2. This act shall take effect on the thirtieth day after it shall have become a law. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD15521-01-2
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.